Rapport d’analyse de la taille, de la part et des tendances du marché mondial du diagnostic respiratoire – Aperçu et prévisions de l’industrie jusqu’en 2031

Analyse du marché du diagnostic respiratoire

Selon le Forum des sociétés respiratoires internationales (FIRS), chaque année, 4 millions de personnes meurent de  maladies respiratoires chroniques . Cela indique que les troubles respiratoires sont en augmentation à l'échelle mondiale. Cela a donné lieu à des innovations de la part des principaux acteurs en matière de produits et de technologies médicales de diagnostic, ouvrant ainsi la voie à la croissance et à l'acceptation des diagnostics respiratoires.

Taille du marché du diagnostic respiratoire

La taille du marché mondial du diagnostic respiratoire a été évaluée à 8,69 milliards USD en 2023 et devrait atteindre 16,08 milliards USD d'ici 2031, avec un TCAC de 8,00 % au cours de la période de prévision de 2024 à 2031.

Portée du rapport et segmentation du marché       

Respiratory Diagnostics Market Definition

From the name itself, it is clear that respiratory diagnostics are the medical products and technologies that are used to diagnose the respiratory diseases and disorders in the patients. Respiratory diagnostics if effective as it can diagnose the diseases at an early stage.

Respiratory Diagnostics Market Dynamics

Drivers

• Rising Prevalence of Conditions

Growing incidence rate of respiratory diseases disorders globally is one of the major factors fostering the growth of the market. Lung cancer, tuberculosis, bronchitis, pneumonia and emphysema are the common respiratory conditions found globally. More than 1 million cases of lung cancer per year are witnessed in India and this condition may prevail for lifetime if not treated properly.    

• Research and Development Proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the advancements in medical technologies and devices is also bolstering the market growth rate.

• Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, growing number of alcohol consumers and smokers and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2024 to 2031. Additionally, unhealthy lifestyle of individuals, rising internet penetration rate, rising geriatric population base, increasing pollution level, product development and commercialization and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, dearth of skilled medical professionals, and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, emergence of alternative technologies, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2024-2031.

This respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Respiratory Diagnostics Market

The COVID-19 pandemic essentially affected the market. This is because of the fact that majority of the healthcare resources were directed towards meeting the demand arising out of COVID-19 patients. Postponement of non-elective surgeries and non-essential healthcare procedures has further derailed the market growth rate in this pandemic period. Lockdowns, quarantines, and social distancing have enhanced many posture-related problems. Further, restrictions imposed on travel owing to the lockdown regulations further challenged the market growth rate in this period. However, the post pandemic period will help to generate profits and revenues.

Respiratory Diagnostics Market Scope

The respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and services

• Instruments and Devices
• Assays and Reagents
• Services and Software

On the basis of product and services, the respiratory diagnostics market is segmented into instruments and devices, assays and reagents and services and software. 

Test type

• Traditional Diagnostic Tests
• Mechanical Tests
• Imaging Tests
• Molecular Diagnostic Tests

On the basis of test type, the respiratory diagnostics market is segmented into traditional diagnostic tests, mechanical tests, imaging tests and molecular diagnostic tests.

Diseases

• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Asthma
• Tuberculosis
• Bronchitis
• Pulmonary Fibrosis
• Other Diseases

End user

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Other End Users

Distribution channel

• Direct Tender
• Retail Sales
• Other

Respiratory Diagnostics Market Regional Analysis

The respiratory diagnostics market is analyzed and market size insights and trends are provided by country, product and services, test type, diseases, end user and distribution channel as referenced above.

The countries covered in the respiratory diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates market because of the rising prevalence of respiratory diseases and growing geriatric population in the region. Asia-Pacific will score the highest CAGR owing to the rising geriatric population base and increasing personal disposable income.  

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Part de marché du diagnostic respiratoire

Le paysage concurrentiel du marché du diagnostic respiratoire fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du diagnostic respiratoire.

Les leaders du marché du diagnostic respiratoire opérant sur le marché sont :

• SOCIÉTÉ GÉNÉRALE D'ÉLECTRICITÉ (ÉTATS-UNIS)
• Koninklijke Philips NV (Pays-Bas)
• Medtronic (Irlande)
• COSMED srl (Italie)
• F. Hoffmann-La Roche SA (Suisse)
• NIHON KOHDEN CORPORATION (Japon)
• Drägerwerk AG & Co. KGaA (Allemagne)
• Bio-Rad Laboratories, Inc. (États-Unis)
• GC Diagnostics Corporation (Corée du Sud)
• Masimo (États-Unis)
• bioMérieux SA (France)
• Carestream Health (États-Unis)
• Thermo Fisher Scientific Inc. (États-Unis)
• Novartis SA (Suisse)
• Abbott (États-Unis)
• Johnson & Johnson Services, Inc. (États-Unis)
• GlaxoSmithKline plc (Royaume-Uni)
• Bayer AG (Allemagne)
• BD (États-Unis)    

SKU-15122